These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15538126)

  • 1. Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies.
    Schneeweiss S; Wang PS
    J Clin Psychopharmacol; 2004 Dec; 24(6):632-8. PubMed ID: 15538126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information.
    Schneeweiss S; Wang PS
    J Am Geriatr Soc; 2005 Jun; 53(6):948-54. PubMed ID: 15935016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data.
    Schneeweiss S; Setoguchi S; Brookhart MA; Kaci L; Wang PS
    CNS Drugs; 2009; 23(2):171-80. PubMed ID: 19173375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis.
    Vangala C; Niu J; Montez-Rath ME; Yan J; Navaneethan SD; Winkelmayer WC
    Am J Kidney Dis; 2020 Mar; 75(3):351-360. PubMed ID: 31606233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude and consequences of misclassification of incident hip fractures in large cohort studies: the Study of Osteoporotic Fractures and Medicare claims data.
    Schousboe JT; Paudel ML; Taylor BC; Virnig BA; Cauley JA; Curtis JR; Ensrud KE
    Osteoporos Int; 2013 Mar; 24(3):801-10. PubMed ID: 23208073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction.
    Schneeweiss S; Glynn RJ; Tsai EH; Avorn J; Solomon DH
    Epidemiology; 2005 Jan; 16(1):17-24. PubMed ID: 15613941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Selective Serotonin Reuptake Inhibitors and Risk of Hip Fracture in the Elderly: A Case-Control Study in Taiwan.
    Hung SC; Lin CH; Hung HC; Lin CL; Lai SW
    J Am Med Dir Assoc; 2017 Apr; 18(4):350-354. PubMed ID: 28159466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
    Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
    Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture.
    Ali MS; Groenwold RH; Belitser SV; Souverein PC; Martín E; Gatto NM; Huerta C; Gardarsdottir H; Roes KC; Hoes AW; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():114-21. PubMed ID: 27038357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zostavax vaccine effectiveness among US elderly using real-world evidence: Addressing unmeasured confounders by using multiple imputation after linking beneficiary surveys with Medicare claims.
    Izurieta HS; Wu X; Lu Y; Chillarige Y; Wernecke M; Lindaas A; Pratt D; MaCurdy TE; Chu S; Kelman J; Forshee R
    Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):993-1001. PubMed ID: 31168897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitor use in hip fracture patients: a Danish nationwide prevalence study.
    Bruun SB; Petersen I; Kristensen NR; Cronin-Fenton D; Pedersen AB
    Acta Orthop; 2019 Feb; 90(1):33-39. PubMed ID: 30526179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension.
    Sadoughi A; Roberts KE; Preston IR; Lai GP; McCollister DH; Farber HW; Hill NS
    Chest; 2013 Aug; 144(2):531-541. PubMed ID: 23558791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data.
    Ivanova JI; Mytelka DS; Duh MS; Birnbaum HG; Cummings AK; San Roman AM; Price GL; Swindle RW
    Patient; 2013; 6(3):189-200. PubMed ID: 23828691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population.
    Blanchette CM; Simoni-Wastila L; Zuckerman IH; Stuart B
    Ann Epidemiol; 2008 Apr; 18(4):316-21. PubMed ID: 18261924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study.
    Nørgaard M; Jacobsen J; Gasse C; Pedersen L; Mortensen PB; Sørensen HT
    J Clin Psychopharmacol; 2007 Jun; 27(3):259-62. PubMed ID: 17502772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.
    Hubbard R; Farrington P; Smith C; Smeeth L; Tattersfield A
    Am J Epidemiol; 2003 Jul; 158(1):77-84. PubMed ID: 12835289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selective serotonin reuptake inhibitors on the risk of fracture.
    Richards JB; Papaioannou A; Adachi JD; Joseph L; Whitson HE; Prior JC; Goltzman D;
    Arch Intern Med; 2007 Jan; 167(2):188-94. PubMed ID: 17242321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
    Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
    J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.